Olanzapine usage associated with neuroleptic malignant syndrome.
Philibert
R A
RA
Department of Psychiatry, University of Iowa, Iowa City 52246, USA. robert-philibert@uiowa.edu
Adam
L A
LA
Frank
F M
FM
Carney-Doebbeling
C
C
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D003863:Depression / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D010300:Parkinson Disease / Q000150:complications*; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012074:Remission Induction; D013406:Suicide, Attempted
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine